Nurosene Health Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Nurosene Health are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Nurosene Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Nurosene Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Nurosene |
Nurosene Health Relative Risk vs. Return Landscape
If you would invest (100.00) in Nurosene Health on October 8, 2025 and sell it today you would earn a total of 100.00 from holding Nurosene Health or generate -100.0% return on investment over 90 days. Nurosene Health is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Nurosene, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Nurosene Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nurosene Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Nurosene Health, and traders can use it to determine the average amount a Nurosene Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MNNDF |
Based on monthly moving average Nurosene Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nurosene Health by adding Nurosene Health to a well-diversified portfolio.
Nurosene Health Fundamentals Growth
Nurosene Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Nurosene Health, and Nurosene Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nurosene Pink Sheet performance.
| Return On Equity | -1.68 | |||
| Return On Asset | -0.53 | |||
| Operating Margin | (65.45) % | |||
| Current Valuation | 3.51 M | |||
| Shares Outstanding | 47.35 M | |||
| Price To Book | 0.35 X | |||
| Price To Sales | 77.09 X | |||
| Revenue | 113.03 K | |||
| EBITDA | (7.34 M) | |||
| Cash And Equivalents | 155.95 K | |||
| Total Debt | 50.6 K | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 0.19 X | |||
| Cash Flow From Operations | (4.78 M) | |||
| Earnings Per Share | (0.21) X | |||
| Total Asset | 9.2 M | |||
Things to note about Nurosene Health performance evaluation
Checking the ongoing alerts about Nurosene Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Nurosene Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nurosene Health is not yet fully synchronised with the market data | |
| Nurosene Health has some characteristics of a very speculative penny stock | |
| Nurosene Health has a very high chance of going through financial distress in the upcoming years | |
| Nurosene Health has accumulated 50.6 K in total debt with debt to equity ratio (D/E) of 0.0, which may suggest the company is not taking enough advantage from borrowing. Nurosene Health has a current ratio of 0.93, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Nurosene Health until it has trouble settling it off, either with new capital or with free cash flow. So, Nurosene Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nurosene Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nurosene to invest in growth at high rates of return. When we think about Nurosene Health's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 113.03 K. Net Loss for the year was (13.45 M) with profit before overhead, payroll, taxes, and interest of 113.03 K. | |
| Nurosene Health has accumulated about 155.95 K in cash with (4.78 M) of positive cash flow from operations. | |
| Roughly 21.0% of Nurosene Health outstanding shares are owned by corporate insiders |
- Analyzing Nurosene Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nurosene Health's stock is overvalued or undervalued compared to its peers.
- Examining Nurosene Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nurosene Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nurosene Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nurosene Health's pink sheet. These opinions can provide insight into Nurosene Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Nurosene Pink Sheet
If you are still planning to invest in Nurosene Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nurosene Health's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |